4-1BB Signaling in Conventional T Cells Drives IL-2 Production That Overcomes CD4+CD25+FoxP3+ T Regulatory Cell Suppression

被引:21
作者
Barsoumian, Hampartsoum B.
Yolcu, Esma S. [1 ,2 ]
Shirwan, Haval [1 ,2 ]
机构
[1] Univ Louisville, Inst Cellular Therapeut, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA
来源
PLOS ONE | 2016年 / 11卷 / 04期
关键词
THERAPEUTIC CANCER VACCINES; MURINE DENDRITIC CELLS; GROWTH-FACTOR-BETA; IFN-GAMMA; MEDIATED APOPTOSIS; IMMUNE-RESPONSES; FOXP3; EXPRESSION; VIVO EXPANSION; CUTTING EDGE; COSTIMULATION;
D O I
10.1371/journal.pone.0153088
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Costimulation with the recombinant SA-4-1BBL agonist of 4-1BB receptor on conventional CD4(+) T cells (Tconvs) overcomes the suppression mediated by naturally occurring CD4(+)CD25(+)FoxP3(+) T regulatory cells (Tregs). The mechanistic basis of this observation has remained largely unknown. Herein we show that Tconvs, but not Tregs, are the direct target of SA-4-1BBL-mediated evasion of Treg suppression. IL-2 produced by Tconvs in response to 4-1BB signaling is both necessary and sufficient for overcoming Treg suppression. Supernatant from Tconvs stimulated with SA-4-1BBL contains high levels of IL-2 and overcomes Treg suppression in ex vivo Tconv: Treg cocultures. Removal of IL-2 from such supernatant restores Treg suppression and repletion of Tconv: Treg cocultures with exogenous recombinant IL-2 overcomes suppression. This study establishes 4-1BB signaling as a key circuit that regulates physical and functional equilibrium between Tregs and Tconvs with important implications for immunotherapy for indications where a fine balance between Tregs and Teffs plays a decisive role.
引用
收藏
页数:13
相关论文
共 49 条
[1]   Interleukin-2: Clinical applications [J].
Atkins, MB .
SEMINARS IN ONCOLOGY, 2002, 29 (03) :12-17
[2]   IFN-γ-STAT1 signal regulates the differentiation of inducible Treg: Potential role for ROS-mediated apoptosis [J].
Chang, Jae-Hoon ;
Kim, Yeon-Jeong ;
Han, Seung-Hee ;
Kang, Chang-Yuil .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (05) :1241-1251
[3]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[4]   4-1BB Functions As a Survival Factor in Dendritic Cells [J].
Choi, Beom K. ;
Kim, Young H. ;
Kwon, Patrick M. ;
Lee, Sang C. ;
Kang, Sang W. ;
Kitu, Moon S. ;
Lee, Myoung J. ;
Kwon, Byoung S. .
JOURNAL OF IMMUNOLOGY, 2009, 182 (07) :4107-4115
[5]   4-1BB-dependent inhibition of immunosuppression by activated CD4+CD25+ T cells [J].
Choi, BK ;
Bae, JS ;
Choi, EM ;
Kang, WJ ;
Sakaguchi, S ;
Vinay, DS ;
Kwon, BS .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (05) :785-791
[6]   Interleukin-2 is essential for CD4+CD25+ regulatory T cell function [J].
de la Rosa, M ;
Rutz, S ;
Dorninger, H ;
Scheffold, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (09) :2480-2488
[7]   IFN-γ, as Secreted during an Alloresponse, Induces Differentiation of Monocytes into Tolerogenic Dendritic Cells, Resulting in FoxP3+ Regulatory T Cell Promotion [J].
Eljaafari, Assia ;
Li, Yin-Ping ;
Miossec, Pierre .
JOURNAL OF IMMUNOLOGY, 2009, 183 (05) :2932-2945
[8]   Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling [J].
Elpek, Kutlu G. ;
Yolcu, Esma S. ;
Franke, Deanna D. H. ;
Lacelle, Chantale ;
Schabowsky, Rich-Henry ;
Shirwan, Haval .
JOURNAL OF IMMUNOLOGY, 2007, 179 (11) :7295-7304
[9]   Expansion and activation of CD4+CD25+ regulatory T cells in Heliomosomoides polygyrus infection [J].
Finney, Constance A. M. ;
Taylor, Matthew D. ;
Wilson, Mark S. ;
Maizels, Rick M. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (07) :1874-1886
[10]   Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells [J].
Futagawa, T ;
Akiba, H ;
Kodama, T ;
Takeda, K ;
Hosoda, Y ;
Yagita, H ;
Okumura, K .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (03) :275-286